clinical trials

News

AZ, Ionis hit by unexpected Wainua trial failure

Prospects for AstraZeneca and Ionis' Wainua have been severely dented by a failed trial in ATTR cardiomyopathy, weighing on the shares of both firms.

News

Kailera's big obesity reveal puts pressure on shares

Fresh from a record-breaking IPO, Kailera revealed keenly anticipated trial results for its oral weight-loss drug, to a mixed reaction.

News

Trial of Bundibugyo Ebola drugs starts in DRC

Patients are now being enrolled in a trial of two potential therapies for Bundibugyo Ebola, Mapp's MBP134 and Gilead's remdesivir, says WHO.

News

Newron charts course forward for stalled schizophrenia drug

Newron thinks it may have reached an agreement with the FDA on a way to get the US development of its schizophrenia candidate evenamide back on track.

R&D

HCP and electronic clinical outcome assessments

Why are eCOA studies still so challenging?

Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.

News

Roche's KRAS drug tops its rivals in lung cancer trial

Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new phase 3 data for its experimental KRAS G12C inhibitor, divarasib.

AZ, Ionis hit by unexpected Wainua trial failure

Kailera's big obesity reveal puts pressure on shares

Trial of Bundibugyo Ebola drugs starts in DRC

Newron charts course forward for stalled schizophrenia drug

Why are eCOA studies still so challenging?

Roche's KRAS drug tops its rivals in lung cancer trial

Trump sets course for 100%, then 200%, tariffs on generics

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks